Diabetes at midlife influences risk of diabetes and cognitive decline in later years
the ONA take:
Substantial cognitive decline is associated with diabetes, prediabetes, and poor glucose control. The potential decline begins at midlife, when poor dietary habits and a lack of exercise leads to diabetes at approximately age 50 years.
These are the findings of a study by researchers at Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. The researchers analyzed data from the Atherosclerosis Risk in Communities Study involving 15,792 middle-age adults who had been followed since 1987.
The participants’ health was assessed approximately every 3 years, and a fifth assessment was conducted between 2011 and 2013. Three of the assessments included analysis of participants’ cognitive function. The rate of cognitive decline among the study participants was compared with age-related cognitive decline in the general population.
The researchers found that study participants with poorly controlled diabetes were 19% more likely to experience cognitive decline, or approximately 5 years sooner than healthy persons of the same age. The researchers conclude that to have a healthy brain at age 70 years, people need to eat right and exercise in their 50s.
Substantial cognitive decline is associated with diabetes, prediabetes, and poor glucose control.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|